Search

Meera Natarajan

Examiner (ID: 11780, Phone: (571)270-3058 , Office: P/1643 )

Most Active Art Unit
1643
Art Unit(s)
1643
Total Applications
1062
Issued Applications
625
Pending Applications
87
Abandoned Applications
376

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5602249 [patent_doc_number] => 20060292594 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'HDAC inhibitors that promote BRM expression and BRM related diagnostics' [patent_app_type] => utility [patent_app_number] => 11/365268 [patent_app_country] => US [patent_app_date] => 2006-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 19338 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20060292594.pdf [firstpage_image] =>[orig_patent_app_number] => 11365268 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/365268
Methods of identifying active BRM expression-promoting HDAC inhibitors Feb 28, 2006 Issued
Array ( [id] => 5619448 [patent_doc_number] => 20060188981 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-24 [patent_title] => 'MN gene and protein' [patent_app_type] => utility [patent_app_number] => 11/356568 [patent_app_country] => US [patent_app_date] => 2006-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 32866 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0188/20060188981.pdf [firstpage_image] =>[orig_patent_app_number] => 11356568 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/356568
MN gene and protein Feb 16, 2006 Issued
Array ( [id] => 7502883 [patent_doc_number] => 08034577 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-10-11 [patent_title] => 'Methods and probes for detecting esophageal cancer' [patent_app_type] => utility [patent_app_number] => 11/356786 [patent_app_country] => US [patent_app_date] => 2006-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 23866 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 229 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/034/08034577.pdf [firstpage_image] =>[orig_patent_app_number] => 11356786 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/356786
Methods and probes for detecting esophageal cancer Feb 16, 2006 Issued
Array ( [id] => 5689198 [patent_doc_number] => 20060287513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Compositions and methods for the therapy and diagnosis of breast cancer' [patent_app_type] => utility [patent_app_number] => 11/352424 [patent_app_country] => US [patent_app_date] => 2006-02-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 47893 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287513.pdf [firstpage_image] =>[orig_patent_app_number] => 11352424 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/352424
Compositions and methods for the therapy and diagnosis of breast cancer Feb 9, 2006 Abandoned
Array ( [id] => 5602246 [patent_doc_number] => 20060292591 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-28 [patent_title] => 'Genes from the 20q13 amplicon and their uses' [patent_app_type] => utility [patent_app_number] => 11/349066 [patent_app_country] => US [patent_app_date] => 2006-02-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 18643 [patent_no_of_claims] => 44 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0292/20060292591.pdf [firstpage_image] =>[orig_patent_app_number] => 11349066 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/349066
Genes from the 20q13 amplicon and their uses Feb 5, 2006 Issued
Array ( [id] => 4726698 [patent_doc_number] => 20080206239 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-08-28 [patent_title] => 'Human Antibodies And Proteins' [patent_app_type] => utility [patent_app_number] => 11/815507 [patent_app_country] => US [patent_app_date] => 2006-02-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 19164 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0206/20080206239.pdf [firstpage_image] =>[orig_patent_app_number] => 11815507 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/815507
Human Antibodies And Proteins Feb 2, 2006 Abandoned
Array ( [id] => 133250 [patent_doc_number] => 07696320 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-04-13 [patent_title] => 'Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor' [patent_app_type] => utility [patent_app_number] => 11/331415 [patent_app_country] => US [patent_app_date] => 2006-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 68 [patent_figures_cnt] => 68 [patent_no_of_words] => 59339 [patent_no_of_claims] => 65 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 75 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/696/07696320.pdf [firstpage_image] =>[orig_patent_app_number] => 11331415 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/331415
Ligands that have binding specificity for VEGF and/or EGFR and methods of use therefor Jan 10, 2006 Issued
Array ( [id] => 177753 [patent_doc_number] => 07655461 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-02 [patent_title] => 'Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC1 tumor associated antigen' [patent_app_type] => utility [patent_app_number] => 11/295767 [patent_app_country] => US [patent_app_date] => 2005-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 16 [patent_no_of_words] => 17092 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/655/07655461.pdf [firstpage_image] =>[orig_patent_app_number] => 11295767 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/295767
Therapeutic and diagnostic cloned MHC-unrestricted receptor specific for the MUC1 tumor associated antigen Dec 6, 2005 Issued
Array ( [id] => 5843222 [patent_doc_number] => 20060121513 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Nuclear targeting sequence' [patent_app_type] => utility [patent_app_number] => 11/293891 [patent_app_country] => US [patent_app_date] => 2005-12-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7939 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20060121513.pdf [firstpage_image] =>[orig_patent_app_number] => 11293891 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/293891
Nuclear targeting sequence Dec 1, 2005 Issued
Array ( [id] => 4432585 [patent_doc_number] => 07968685 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-06-28 [patent_title] => 'Antibodies against Tenascin-C' [patent_app_type] => utility [patent_app_number] => 11/718919 [patent_app_country] => US [patent_app_date] => 2005-10-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13263 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 64 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/968/07968685.pdf [firstpage_image] =>[orig_patent_app_number] => 11718919 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/718919
Antibodies against Tenascin-C Oct 30, 2005 Issued
Array ( [id] => 22772 [patent_doc_number] => 07794713 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-14 [patent_title] => 'Compositions and methods for the treatment and prevention of hyperproliferative diseases' [patent_app_type] => utility [patent_app_number] => 11/261935 [patent_app_country] => US [patent_app_date] => 2005-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 21 [patent_no_of_words] => 18718 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 57 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/794/07794713.pdf [firstpage_image] =>[orig_patent_app_number] => 11261935 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/261935
Compositions and methods for the treatment and prevention of hyperproliferative diseases Oct 27, 2005 Issued
Array ( [id] => 5842249 [patent_doc_number] => 20060121042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-08 [patent_title] => 'Modulation of antibody specificity by tailoring the affinity to cognate antigens' [patent_app_type] => utility [patent_app_number] => 11/259133 [patent_app_country] => US [patent_app_date] => 2005-10-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 63 [patent_figures_cnt] => 63 [patent_no_of_words] => 76824 [patent_no_of_claims] => 64 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0121/20060121042.pdf [firstpage_image] =>[orig_patent_app_number] => 11259133 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/259133
Modulation of antibody specificity by tailoring the affinity to cognate antigens Oct 26, 2005 Abandoned
Array ( [id] => 5040665 [patent_doc_number] => 20070092947 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Methods and compositions for increasing longevity and protein yield from a cell culture' [patent_app_type] => utility [patent_app_number] => 11/253666 [patent_app_country] => US [patent_app_date] => 2005-10-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 28 [patent_figures_cnt] => 28 [patent_no_of_words] => 14014 [patent_no_of_claims] => 103 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20070092947.pdf [firstpage_image] =>[orig_patent_app_number] => 11253666 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/253666
Methods and compositions for increasing longevity and protein yield from a cell culture Oct 19, 2005 Abandoned
Array ( [id] => 585367 [patent_doc_number] => 07446176 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-11-04 [patent_title] => '12 human secreted proteins' [patent_app_type] => utility [patent_app_number] => 11/246999 [patent_app_country] => US [patent_app_date] => 2005-10-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 67 [patent_figures_cnt] => 67 [patent_no_of_words] => 290534 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/446/07446176.pdf [firstpage_image] =>[orig_patent_app_number] => 11246999 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/246999
12 human secreted proteins Oct 10, 2005 Issued
Array ( [id] => 5865076 [patent_doc_number] => 20060099206 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-11 [patent_title] => 'Methods and compositions for improving recombinant protein production' [patent_app_type] => utility [patent_app_number] => 11/244678 [patent_app_country] => US [patent_app_date] => 2005-10-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 15932 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20060099206.pdf [firstpage_image] =>[orig_patent_app_number] => 11244678 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/244678
Methods and compositions for improving recombinant protein production Oct 4, 2005 Issued
Array ( [id] => 5225578 [patent_doc_number] => 20070254845 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-11-01 [patent_title] => 'Nucleophosmin/B23-binding peptide to inhibit tumor growth and regulate transcriptional activity of p53' [patent_app_type] => utility [patent_app_number] => 11/239032 [patent_app_country] => US [patent_app_date] => 2005-09-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 4816 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0254/20070254845.pdf [firstpage_image] =>[orig_patent_app_number] => 11239032 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/239032
Nucleophosmin/B23-binding peptide to inhibit tumor growth and regulate transcriptional activity of p53 Sep 29, 2005 Issued
Array ( [id] => 5814027 [patent_doc_number] => 20060084124 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Localization of A2B AdoR on human normal and diseased tissue: the use of anti-A2B antibody to diagnose and treat human tumors' [patent_app_type] => utility [patent_app_number] => 11/237086 [patent_app_country] => US [patent_app_date] => 2005-09-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 4865 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084124.pdf [firstpage_image] =>[orig_patent_app_number] => 11237086 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/237086
Localization of A2B AdoR on human normal and diseased tissue: the use of anti-A2B antibody to diagnose and treat human tumors Sep 26, 2005 Abandoned
Array ( [id] => 5040658 [patent_doc_number] => 20070092940 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-04-26 [patent_title] => 'Cysteine engineered antibodies and conjugates' [patent_app_type] => utility [patent_app_number] => 11/233258 [patent_app_country] => US [patent_app_date] => 2005-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 26 [patent_no_of_words] => 47087 [patent_no_of_claims] => 126 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0092/20070092940.pdf [firstpage_image] =>[orig_patent_app_number] => 11233258 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/233258
Cysteine engineered antibodies and conjugates Sep 21, 2005 Issued
Array ( [id] => 5742797 [patent_doc_number] => 20060088522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-27 [patent_title] => 'Humanized anti-5T4 antibodies and anti-5T4/calicheamicin conjugates' [patent_app_type] => utility [patent_app_number] => 11/221902 [patent_app_country] => US [patent_app_date] => 2005-09-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 63 [patent_figures_cnt] => 63 [patent_no_of_words] => 31707 [patent_no_of_claims] => 49 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0088/20060088522.pdf [firstpage_image] =>[orig_patent_app_number] => 11221902 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/221902
Humanized anti-5T4 antibodies and anti-5T4/calicheamicin conjugates Sep 8, 2005 Abandoned
Array ( [id] => 590884 [patent_doc_number] => 07435806 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-10-14 [patent_title] => 'Nucleic acid binding of multi-zinc finger transcription factors' [patent_app_type] => utility [patent_app_number] => 11/196670 [patent_app_country] => US [patent_app_date] => 2005-08-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 22365 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 16 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/435/07435806.pdf [firstpage_image] =>[orig_patent_app_number] => 11196670 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/196670
Nucleic acid binding of multi-zinc finger transcription factors Aug 2, 2005 Issued
Menu